Dr. Bethann M. Scarborough
Overview
Bethann Scarborough is a Palliative Medicine provider in Lancaster, Pennsylvania. Dr. Scarborough is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Opioid Induced Constipation, Smoldering Multiple Myeloma, and Relapsed Refractory Multiple Myeloma (RRMM). Dr. Scarborough is currently accepting new patients.
Her clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2102 Harrisburg Pike, Lancaster, PA 17601
609 N. Cherry St., Lancaster, PA 17602
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Medical Oncology Hematology Consultants PA
Andrew Himelstein is a Hematologist Oncology specialist and a Palliative Medicine provider in Newark, Delaware. Dr. Himelstein is rated as a Distinguished provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Familial Prostate Cancer. Dr. Himelstein is currently accepting new patients.
Penn State Health Community Medical Group LLC
Kristina Newport is a Palliative Medicine provider in Camp Hill, Pennsylvania. Dr. Newport is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Opioid Induced Constipation, ALK-Positive Non-Small Cell Lung Cancer, Gastroesophageal Junction Cancer, and Smoldering Multiple Myeloma.
Main Line Healthcare
Sandra Urtishak is a Hematologist Oncology specialist and a Palliative Medicine provider in Paoli, Pennsylvania. Dr. Urtishak is rated as an Advanced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Laryngeal Cancer, and Throat Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Opioid Induced ConstipationDr. Scarborough isExperienced. Learn about Opioid Induced Constipation.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Scarborough isExperienced. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Smoldering Multiple MyelomaDr. Scarborough isExperienced. Learn about Smoldering Multiple Myeloma.